Prostate Cancer - Results from #20

Next generation sequencing (NGS)-based molecular panel analysis for metastatic prostate cancer: how often can we detect druggable mutations? : NGS for metastatic adenocarcinoma of the prostate. January 24, 2025

Real-world effectiveness and cardiovascular safety of abiraterone versus enzalutamide amongst older patients diagnosed with metastatic castration-resistant prostate cancer. January 24, 2025

Prospective Validation of an Automated Hybrid Multidimensional MRI Tool for Prostate Cancer Detection Using Targeted Biopsy: Comparison with PI-RADS-based Assessment. January 24, 2025

An AI-Digital Pathology Algorithm Predicts Survival after Radical Prostatectomy from the PLCO Trial. January 24, 2025

Prostate-specific Membrane Antigen-radioguided Surgery in an EMBARK-like Cohort of Patients with Oligorecurrent Hormone-sensitive Prostate Cancer: Delay in Systemic Treatment. January 24, 2025

Clinical Validation of MyProstateScore 2.0 Testing Using First-Catch, Non-DRE Urine. January 23, 2025

Clinical significance of stratifying prostate cancer patients through specific circulating genes. January 23, 2025

Bridging the gap: Evaluating ChatGPT-generated, personalized, patient-centered prostate biopsy reports. January 23, 2025

Treatment algorithm following first-line therapy failure in metastatic prostate cancer. January 23, 2025

The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care. January 23, 2025

Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial. January 23, 2025

Men's Attitudes Towards Participation in Organised Prostate Cancer Testing: An Abductive Thematic Analysis. January 22, 2025

Online correction of intrafraction motion during volumetric modulated arc therapy for prostate radiotherapy using fiducial-based kV imaging: A cohort study quantifying the frequency of shifts and analysis of men at highest risk. January 22, 2025

Impact of Genomic Classifiers on Risk Stratification and Treatment Intensity in Patients With Localized Prostate Cancer : A Systematic Review. January 22, 2025

Cancer-specific mortality after radical prostatectomy versus radiotherapy in incidental prostate cancer. January 22, 2025

« Augmented radiotherapy » in the management of high-risk prostate cancer (PCa): a systematic review. January 22, 2025

Prognostic value of MR visibility/invisibility in men on Active Surveillance. January 21, 2025

Low baseline IsoPSA Index is associated with a Prolonged Low Risk of Clinically Significant Prostate Cancer Diagnosis in Men with an Elevated PSA. January 21, 2025

Personalized Dynamic Prediction Model for Biopsy Timing in Patients With Prostate Cancer During Active Surveillance. January 21, 2025

PSMA+ Extracellular Vesicles are a Biomarker for SABR in Oligorecurrent Prostate Cancer Analysis from the STOMP-like and ORIOLE trial cohorts. January 21, 2025

Page 2 of 1455